First Citizens BancShares, Inc.
First Citizens BancShares, Inc. (FCNCB) Financial Performance & Income Statement Overview
Analyze First Citizens BancShares, Inc. (FCNCB) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
First Citizens BancShares, Inc. (FCNCB) Income Statement & Financial Overview
Analyze First Citizens BancShares, Inc.’s FCNCB earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.52B | $3.69B | $3.78B | $3.71B |
| Cost of Revenue | $1.39B | $1.45B | $1.46B | $1.40B |
| Gross Profit | $2.14B | $2.24B | $2.32B | $2.30B |
| Gross Profit Ratio | $0.61 | $0.61 | $0.61 | $0.62 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $946.00M | $913.00M | $898.00M | $856.00M |
| Operating Expenses | $1.49B | $1.51B | $1.45B | $1.32B |
| Total Costs & Expenses | $2.87B | $2.95B | $2.91B | $2.73B |
| Interest Income | $2.90B | $3.001B | $3.14B | $3.13B |
| Interest Expense | $1.23B | $1.29B | $1.34B | $1.31B |
| Depreciation & Amortization | $93.00M | $94.00M | $42.00M | $6.00M |
| EBITDA | $744.00M | $830.00M | $915.00M | $985.00M |
| EBITDA Ratio | $0.21 | $0.22 | $0.24 | $0.27 |
| Operating Income | $651.00M | $736.00M | $873.00M | $979.00M |
| Operating Income Ratio | $0.18 | $0.20 | $0.23 | $0.26 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $651.00M | $736.00M | $873.00M | $979.00M |
| Income Before Tax Ratio | $0.18 | $0.20 | $0.23 | $0.26 |
| Income Tax Expense | $168.00M | $36.00M | $234.00M | $272.00M |
| Net Income | $483.00M | $700.00M | $639.00M | $707.00M |
| Net Income Ratio | $0.14 | $0.19 | $0.17 | $0.19 |
| EPS | $34.47 | $49.21 | $43.41 | $47.54 |
| Diluted EPS | $34.47 | $49.21 | $43.41 | $47.54 |
| Weighted Avg Shares Outstanding | $13.57M | $13.93M | $14.38M | $14.53M |
| Weighted Avg Shares Outstanding (Diluted) | $13.57M | $13.93M | $14.38M | $14.53M |
The company's financials show resilient growth, with revenue advancing from $3.71B in Q2 2024 to $3.52B in Q1 2025. Gross profit remained healthy with margins at 61% in Q1 2025 compared to 62% in Q2 2024. Operating income hit $651.00M last quarter, sustaining a consistent 18% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $744.00M. Net income dropped to $483.00M, while earnings per share reached $34.47. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan